Astral Ltd

Q2 FY25 Earnings Call Analysis

Industrial Products

Full Stock Analysis
fundraise: Nocapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
πŸ“‹

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The call transcript does not explicitly mention the current or expected order book or pending orders in numeric terms. - However, positive pointers indicate an improving demand outlook: - Volume started picking up from July onwards after a flat Q1. - PVC anti-dumping duty expected this quarter is anticipated to aid volume and value growth. - Government spending on OPVC lines is expected to restart, leading to good orders. - Upcoming Kanpur plant (ready in Q3) will support growth in North markets (UP, Bihar, NCR). - Demand revival is expected between the third week of August and Diwali due to home improvement activities. - Industry challenges persist, but good prospects are expected in the near future. - Management is committed to growth and expects double-digit volume growth for FY '26. In summary, while specific orderbook numbers are not disclosed, management expresses optimism on improving order inflows and demand.
πŸ’°

fundraise

Any current/future new fundraising through debt or equity?

- There is no explicit mention of any immediate or planned new fundraising through debt or equity in the provided pages. - The company has recently made a backward integration announcement involving investment in a CPVC resin plant with a total CAPEX around Rs. 150 crores, with 20% funded by a technical partner. - Management indicated that after a heavy CAPEX cycle in the last three years (~Rs. 1,500 crores), the CAPEX would be on hold for the next 2-3 years except for maintenance. - Cash flows from existing and new businesses (adhesives, bathware, paint) are expected to generate sufficient internal resources for growth. - Any future acquisition or investment opportunities will be evaluated but currently, nothing specific is indicated regarding additional fundraising. - The focus is on organic growth and efficient utilization of past CAPEX rather than raising new funds in near term.
πŸ—οΈ

capex

Any current/future capex/capital investment/strategic investment?

- Astral has invested around Rs. 1,500 crores in CAPEX over the last three years, impacting ROE due to market conditions. - This year’s CAPEX guidance is around Rs. 300 crores, with Rs. 50 crores expected in Q1. - Additional Rs. 120 crores CAPEX is planned for a backward integration CPVC resin plant, spread over 12 months. - After this year, CAPEX for the pipe division will largely be maintenance-driven, with no major expansions planned for 2-3 years. - The CPVC plant (40,000 tons capacity) will serve 100% captive use initially; future capacity may increase as demand grows. - Plans to stop major CAPEX cycles soon to improve capital efficiency, with operational utilization expected to enhance returns. - Astral is open to future acquisitions/opportunities to fuel growth, but no immediate surprise items on the cards.
πŸ“Š

revenue

Future growth expectations in sales/revenue/volumes?

- Astral expects a minimum double-digit volume growth over the next five years, with potential for higher growth due to upcoming backward integration (Page 29). - The new CPVC resin manufacturing plant (40,000 tons capacity) is expected to be operational by Q2 FY '27, which will improve margins and production stability (Pages 15, 24, 29). - New businesses like Bathware and Paints have low current market share but are expected to grow faster than established segments, with Paints targeting a minimum 20% growth by year-end (Pages 24, 29). - The piping division grew 30% year-on-year in July, and sustainable double-digit growth is expected despite recent polymer price challenges (Pages 16, 29). - If favorable policies like anti-dumping duties and BIS certifications materialize, volume growth could exceed 15% (Page 28). - The management emphasizes long-term growth focus, willing to trade slight margin reductions for volume gains when justified (Pages 16, 29).
πŸ“ˆ

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Astral expects a minimum double-digit volume growth over the next five years, possibly higher with the upcoming backward integration plant. - New businesses like Bathware are anticipated to grow faster than established ones, contributing significantly to top-line growth. - Despite recent polymer price challenges, Astral foresees double-digit growth as achievable, supported by market recovery and new capacity coming online in the second half of next year. - EBITDA margins are expected to be maintained or improved, with the piping business aiming for 16-18% annual EBITDA margins. - The CPVC plant with 40,000-ton capacity is anticipated to enhance margins and volume, starting commercial production by Q2 FY '27. - Improvements in EBITDA and operating efficiency expected as CAPEX cycle concludes within two to three years, driving better ROI and ROC. - With factors like anti-dumping duties (ADD) and government spending potentially favorable, growth could reach 15% or more.